The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Negative Fluid-Attenuated Inversion Recovery- Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time
Open accessAbstract
Background: Approximately 25% of acute stroke patients were excluded from intravenous thrombolysis using recombinant tissue plasminogen activator (IV-tPA) because of unknown onset time. Recent studies have shown that patients with unknown onset time would be able to receive IV-tPA when showing no ischemia on fluid-attenuated inversion recovery (negative FLAIR). The present study evaluated the safety and feasibility of IV-tPA in patients with unknown onset time and negative FLAIR compared to those with standard IV-tPA. Methods: Stroke patients with unknown onset time were prospectively enrolled. Only patients with an occlusion of the internal carotid artery (ICA) and/or middle cerebral artery (M1 and M2) with a Diffusion-Weighted Imaging-Alberta Stroke Program Early CT Score (DWI-ASPECTS) ≥5 were analyzed. IV-tPA was performed within 3 h from the ‘first found abnormal time' if the patient showed negative FLAIR. Standard IV-tPA patients were extracted from our registry as controls after having been matched by age and occluded artery to the negative FLAIR (N-F) group. Results: Twenty patients in the N-F group and 60 in the control group were included. National Institutes of Health Stroke Scale (NIHSS) scores [median 18 (interquartile range 13-20) vs. 17 (12-20), p = 0.609] and DWI-ASPECTS [9 (7-9) vs. 8 (5-9), p = 0.213] were similar between the 2 groups. ICA occlusion was seen in 35%, M1 in 50%, and M2 in 15% in both groups. None of the N-F group and 1 (2%) of the control group experienced symptomatic intracerebral hemorrhage (p = 1.000). Recanalization within 1 h after IV-tPA was achieved in 6 (30%) patients in the N-F group and 24 (40%) in the control group (p = 0.595). Recanalization at 24 h after IV-tPA was seen in 13 (65%) patients in the N-F group and 43 (72%) in the control group (p = 0.584). At 7 days, 8 (40%) in the N-F group and 28 (47%) in the control group had a dramatic recovery (defined as a ≥10-point reduction in the total NIHSS score or a score of 0 or 1) (p = 0.796). At 3 months, a favorable outcome (modified Rankin scale score, 0-2) was seen in 47% in the N-F group and 33% in the control group (p = 0.365). Conclusion: IV-tPA in negative FLAIR patients with unknown onset time appears safe and feasible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
Saqqur, M., Uchino, K., Demchuk, A. M., Molina, C. A., Garami, Z., Calleja, S., Akhtar, N., Orouk, F. O., Salam, A., Shuaib, A., et al. (2007) · Stroke · doi:10.1161/01.str.0000257304.21967.ba · Cited by 688
Thomalla, G., Cheng, B., Ebinger, M., Hao, Q., Tourdias, T., Wu, O., Kim, J. S., Breuer, L., Singer, O. C., Warach, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70192-2 · Cited by 602
Yamaguchi, T., Mori, E., Minematsu, K., Nakagawara, J., Hashi, K., Saito, I., & Shinohara, Y. (2006) · Stroke · doi:10.1161/01.str.0000227191.01792.e3 · Cited by 515
Rubiera, M., Ribo, M., Delgado-Mederos, R., Santamarina, E., Delgado, P., Montaner, J., Alvarez-Sabín, J., & Molina, C. A. (2006) · Stroke · doi:10.1161/01.str.0000237070.80133.1d · Cited by 421
Thomalla, G., Rossbach, P., Rosenkranz, M., Siemonsen, S., Krützelmann, A., Fiehler, J., & Gerloff, C. (2009) · Annals of Neurology · doi:10.1002/ana.21651 · Cited by 248
Population-based study of wake-up strokes
Mackey, J., Kleindorfer, D., Sucharew, H., Moomaw, C. J., Kissela, B. M., Alwell, K., Flaherty, M. L., Woo, D., Khatri, P., Adeoye, O., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318219fb30 · Cited by 242
Fink, J. N., Kumar, S., Horkan, C., Linfante, I., Selim, M. H., Caplan, L. R., & Schlaug, G. (2002) · Stroke · doi:10.1161/01.str.0000014585.17714.67 · Cited by 233
Cited by
Emberson, J., Lees, K. R., Lyden, P., Blackwell, L., Albers, G., Bluhmki, E., Brott, T., Cohen, G., Davis, S., Donnan, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60584-5 · Cited by 2,737
Treatment Strategies for Acute Ischemic Stroke Caused by Carotid Artery Occlusion
Li, W., Yin, Q., Xu, G., & Liu, X. (2016) · Interventional Neurology · doi:10.1159/000445304 · Cited by 2,319
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Berge, E., Whiteley, W., Audebert, H., De Marchis, G., Fonseca, A. C., Padiglioni, C., Pérez de la Ossa, N., Strbian, D., Tsivgoulis, G., & Turc, G. (2021) · European Stroke Journal · doi:10.1177/2396987321989865 · Cited by 1,355
Wardlaw, J. M., Murray, V., Berge, E., del Zoppo, G., Sandercock, P., Lindley, R. L., & Cohen, G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60738-7 · Cited by 1,010
Management of Acute Ischemic Stroke
Herpich, F., & Rincon, F. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004597 · Cited by 933
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke
Yang, C., Hawkins, K. E., Doré, S., & Candelario-Jalil, E. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00136.2018 · Cited by 871
Lackland, D. T., Roccella, E. J., Deutsch, A. F., Fornage, M., George, M. G., Howard, G., Kissela, B. M., Kittner, S. J., Lichtman, J. H., Lisabeth, L. D., et al. (2014) · Stroke · doi:10.1161/01.str.0000437068.30550.cf · Cited by 815
Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials
Broderick, J. P., Adeoye, O., & Elm, J. (2017) · Stroke · doi:10.1161/strokeaha.117.017866 · Cited by 807
Powers, W. J., Clarke, W. R., Grubb, R. L., Videen, T. O., Adams, H. P., Derdeyn, C. P., & COSS Investigators, F. T. (2011) · JAMA · doi:10.1001/jama.2011.1610 · Cited by 803
Frontera, J. A., Lewin III, J. J., Rabinstein, A. A., Aisiku, I. P., Alexandrov, A. W., Cook, A. M., del Zoppo, G. J., Kumar, M. A., Peerschke, E. I. B., Stiefel, M. F., et al. (2016) · Neurocritical Care · doi:10.1007/s12028-015-0222-x · Cited by 706
Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic
Zhang, Z. G., & Chopp, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70061-4 · Cited by 596
Fransen, P. S., Beumer, D., Berkhemer, O. A., van den Berg, L. A., Lingsma, H., van der Lugt, A., van Zwam, W. H., van Oostenbrugge, R. J., Roos, Y. B., Majoie, C. B., et al. (2014) · Trials · doi:10.1186/1745-6215-15-343 · Cited by 551
Suzuki, K., Matsumaru, Y., Takeuchi, M., Morimoto, M., Kanazawa, R., Takayama, Y., Kamiya, Y., Shigeta, K., Okubo, S., Hayakawa, M., et al. (2021) · JAMA · doi:10.1001/jama.2020.23522 · Cited by 545
Self-citationThrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke
Jolugbo, P., & Ariëns, R. A. S. (2021) · Stroke · doi:10.1161/strokeaha.120.032810 · Cited by 526
Sun, M.-S., Jin, H., Sun, X., Huang, S., Zhang, F.-L., Guo, Z.-N., & Yang, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3804979 · Cited by 502
Jurcau, A., & Simion, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010014 · Cited by 500
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Lansberg, M. G., O'Donnell, M. J., Khatri, P., Lang, E. S., Nguyen-Huynh, M. N., Schwartz, N. E., Sonnenberg, F. A., Schulman, S., Vandvik, P. O., Spencer, F. A., et al. (2012) · Chest · doi:10.1378/chest.11-2302 · Cited by 455
Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments
George, P. M., & Steinberg, G. K. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.041 · Cited by 393
Recent advances in the management of acute ischemic stroke
Chang, P., & Prabhakaran, S. (2017) · F1000Research · doi:10.12688/f1000research.9191.1 · Cited by 379
Diagnosis and management of acute ischemic stroke: speed is critical
Musuka, T. D., Wilton, S. B., Traboulsi, M., & Hill, M. D. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.140355 · Cited by 358
Liu, L., Chen, W., Zhou, H., Duan, W., Li, S., Huo, X., Xu, W., Huang, L., Zheng, H., Liu, J., et al. (2020) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000378 · Cited by 349
Chen, Y.-C., Ma, N.-X., Pei, Z.-F., Wu, Z., Do-Monte, F. H., Keefe, S., Yellin, E., Chen, M. S., Yin, J.-C., Lee, G., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.09.003 · Cited by 312
Randomized controlled trials – a matter of design
Siepmann, T., Spieth, P. M., Kubasch, A. S., Penzlin, A. I., Illigens, B. M.-W., & Barlinn, K. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s101938 · Cited by 292
Zhu, Z., Fu, Y., Tian, D., Sun, N., Han, W., Chang, G., Dong, Y., Xu, X., Liu, Q., Huang, D., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016371 · Cited by 291
Impact of an immune modulator fingolimod on acute ischemic stroke
Fu, Y., Zhang, N., Ren, L., Yan, Y., Sun, N., Li, Y.-J., Han, W., Xue, R., Liu, Q., Hao, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416166111 · Cited by 288
The neurovascular unit in the setting of stroke
Del Zoppo, G. J. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02199.x · Cited by 285
Menon, B. K., Al-Ajlan, F. S., Najm, M., Puig, J., Castellanos, M., Dowlatshahi, D., Calleja, A., Sohn, S.-I., Ahn, S. H., Poppe, A., et al. (2018) · JAMA · doi:10.1001/jama.2018.12498 · Cited by 284
Epidemiology, Natural History, and Clinical Presentation of Large Vessel Ischemic Stroke
Rennert, R. C., Wali, A. R., Steinberg, J. A., Santiago-Dieppa, D. R., Olson, S. E., Pannell, J. S., & Khalessi, A. A. (2019) · Neurosurgery · doi:10.1093/neuros/nyz042 · Cited by 283
Oxidative Stress and the Use of Antioxidants in Stroke
Shirley, R., Ord, E., & Work, L. (2014) · Antioxidants · doi:10.3390/antiox3030472 · Cited by 282
Saver, J. L., Goyal, M., Bonafe, A., Diener, H.-C., Levy, E. I., Pereira, V. M., Albers, G. W., Cognard, C., Cohen, D. J., Hacke, W., et al. (2015) · International Journal of Stroke · doi:10.1111/ijs.12459 · Cited by 279
Naqvi, J., Yap, K. H., Ahmad, G., & Ghosh, J. (2013) · International Journal of Vascular Medicine · doi:10.1155/2013/629378 · Cited by 279
RIGOR Guidelines: Escalating STAIR and STEPS for Effective Translational Research
Lapchak, P. A., Zhang, J. H., & Noble-Haeusslein, L. J. (2013) · Translational Stroke Research · doi:10.1007/s12975-012-0209-2 · Cited by 274
Nouh, A., Remke, J., & Ruland, S. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00030 · Cited by 264
Lees, K. R., Emberson, J., Blackwell, L., Bluhmki, E., Davis, S. M., Donnan, G. A., Grotta, J. C., Kaste, M., von Kummer, R., Lansberg, M. G., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.013644 · Cited by 256
Tau exacerbates excitotoxic brain damage in an animal model of stroke
Bi, M., Gladbach, A., van Eersel, J., Ittner, A., Przybyla, M., van Hummel, A., Chua, S. W., van der Hoven, J., Lee, W. S., Müller, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00618-0 · Cited by 167
Exosomes and stem cells in degenerative disease diagnosis and therapy
Chang, Y.-H., Wu, K.-C., Harn, H.-J., Lin, S.-Z., & Ding, D.-C. (2018) · Cell Transplantation · doi:10.1177/0963689717723636 · Cited by 159
Liu, H., Wang, Y., Xiao, Y., Hua, Z., Cheng, J., & Jia, J. (2016) · Translational Stroke Research · doi:10.1007/s12975-016-0459-5 · Cited by 80
Härtig, W., Mages, B., Aleithe, S., Nitzsche, B., Altmann, S., Barthel, H., Krueger, M., & Michalski, D. (2017) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2017.00015 · Cited by 53
The effects of telemedicine on racial and ethnic disparities in access to acute stroke care
Lyerly, M. J., Wu, T.-C., Mullen, M. T., Albright, K. C., Wolff, C., Boehme, A. K., Branas, C. C., Grotta, J. C., Savitz, S. I., & Carr, B. G. (2016) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x15589534 · Cited by 52
Stroke during sleep and obstructive sleep apnea: there is a link
Mohammad, Y., Almutlaq, A., Al-Ruwaita, A., Aldrees, A., Alsubaie, A., & Al-Hussain, F. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03753-2 · Cited by 32
A dose–response study of thymosin β4 for the treatment of acute stroke.
Morris, D. C., Cui, Y., Cheung, W. L., Lu, M., Zhang, L., Zhang, Z. G., & Chopp, M. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.07.006 · Cited by 31
Self-fulfilling prophecies and machine learning in resuscitation science
De-Arteaga, M., & Elmer, J. (2023) · Resuscitation · doi:10.1016/j.resuscitation.2022.10.014 · Cited by 28
Michalski, D., Pitsch, R., Pillai, D. R., Mages, B., Aleithe, S., Grosche, J., Martens, H., Schlachetzki, F., & Härtig, W. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174996 · Cited by 15
Liang, J., Luo, C., Ke, S., & Tung, T.-H. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102340 · Cited by 14
Feng, J., Zhang, Q., Wu, F., Peng, J., Li, Z., & Chen, Z. (2023) · Journal of Medical Internet Research · doi:10.2196/44895 · Cited by 12
Metadata
- Authors
- Aoki, J., Kimura, K., Shibazaki, K., & Sakamoto, Y.
- Venue
- Cerebrovascular Diseases Extra
- Publisher
- S. Karger AG
- Published
- 2013-03-23
- Volume
- 3
- Issue
- 1
- Pages
- 35-45
- ISSN
- 1664-5456 (ISSN-L)
- OpenAlex
- W2102447759
- Cited by
- 1,929
- References
- 23
- FWCI
- 95.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.